AvantGuard, Inc.
United States
- Ithaca, New York
- 12/05/2023
- Seed
- $2,850,000
AvantGuardā¢, formerly Halomine, is revolutionizing the fight against harmful pathogens with our innovative technology that provides long-term protection against viruses, bacteria, and fungi/mold. Our proprietary combinations of specialty molecules and polymers are customized to deliver prolonged antimicrobial efficacy to a wide range of surfaces and materials, making them ideal for use in healthcare, food processing, and hospitality industries.
Did you know that hospital-acquired infections and food-borne illnesses cost the world over $100B annually? Unlike current disinfectants that only offer temporary (15-minute) protection, AvantGuard's groundbreaking technology effectively holds chlorine from standard disinfectants on surfaces for as long as a month, extending the lifetime and overall utility of chlorine to continuously protect a variety of surfaces.
Halomine Inc. was founded in 2018 as a Cornell University-based spin-out company. Since then, we have partnered with world-renowned universities, programs, incubators, and scientists to expand on our original research. We have also licensed N-halamine technology from both Cornell and Auburn University, where they have been working on N-halamine development for 30 years. Our technology has been recognized with several grants, awards, and partnerships with leading organizations in surface protection and beyond.
Visit our website at https://www.avantguardinc.com/ to learn more about how AvantGuard can help protect you and your surfaces from harmful pathogens.
- Industry Chemical Manufacturing
- Website https://www.linkedin.com/company/avantguard-inc/
- LinkedIn https://www.avantguardinc.com/
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)